LEMS NEWS & EVENTS

Find more information about Lambert-Eaton myasthenic syndrome (LEMS), FIRDAPSE, and other related topics and events.

COVID-19 and LEMS Patients

“A Look at LEMS” Patient Webinar

What LEMS patients and caregivers should know about COVID-19

EXPERT RECOMMENDATIONS FOR LEMS PATIENTS DURING THE PANDEMIC

An international group of scientists released treatment guidelines for patients with LEMS and related neuromuscular conditions during the COVID-19 pandemic.

Here is a summary of their key findings and recommendations that LEMS patients and their caregivers should be aware of:

Continue current LEMS treatment and medications unless the doctor instructs otherwise
There is no scientific evidence to suggest that amifampridine—the medicine in FIRDAPSE—increases the risk of infection. Treatment with FIRDAPSE should be continued unless the doctor instructs otherwise
Patients with LEMS taking immunosuppressive therapies may be at increased risk of contracting COVID-19 or having a more severe course of disease and should ask their doctor if immunosuppressive therapy should be paused
If a LEMS patient is receiving infusion therapy from a hospital or center, consult with the doctor about the possibility of switching to in-home infusion until the pandemic has passed
Avoid live vaccines; LEMS patients should only receive vaccines that have been heat-killed

IF A LEMS PATIENT BECOMES INFECTED WITH COVID-19 AND HAS:

Man icon

Mild symptoms: Patient should continue their current treatment as directed by their physician

Hospital icon

Severe symptoms (requiring hospitalization): Talk to the doctor about pausing immunosuppression therapy until hospitalization is over

“A Look at LEMS” patient webinar

A Look at LEMS logo

This on-demand educational webinar allows patients to learn more about LEMS from a neuromuscular specialist, hear the personal journey of a woman living with LEMS, and find opportunities for support.

writing

SIGN UP TO STAY INFORMED

Receive the latest information about FIRDAPSE and LEMS.
Phone

CONTACT A CARE COORDINATOR

Call 1-833-4-CATALYST
(1-833-422-8259),
Monday-Friday, 7AM-7PM CST.

We'd love to hear from you!

Ready to take a short survey (3–5 minutes) to tell us more about you and your experience on our website?

Catalyst Pharmaceuticals respects your personal health information. The information you provide may be used to send you relevant health-related materials and to develop products, services, and programs for the communities that we serve. Catalyst Pharmaceuticals or third parties working on our behalf will not sell or rent personal health information. Your information will only be used in accordance with the Catalyst Privacy Policy.

If you later wish to opt out of receiving this information, you may click on the included opt-out link in future communications.

By completing this registration, you confirm that you are 18 years of age or older and a US resident.

THANK YOU!

We’ll be in touch soon.

What is FIRDAPSE®?

FIRDAPSE is a prescription medicine used to treat adults 17 years of age or older with Lambert-Eaton myasthenic syndrome (LEMS). The safety and efficacy of FIRDAPSE in patients under the age of 17 has not been established.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about FIRDAPSE?

  • FIRDAPSE can cause seizures.
    • You could have a seizure even if you never had a seizure before.
    • Do not take FIRDAPSE if you have ever had a seizure.

Stop taking FIRDAPSE and call your doctor right away if you have a seizure while taking FIRDAPSE.

Do not take FIRDAPSE if you:

  • have ever had a seizure.
  • are allergic to amifampridine phosphate, or another aminopyridine.

Before you take FIRDAPSE, tell your doctor about all of your medical conditions, including if you:

  • are taking another aminopyridine, such as compounded 3,4-diaminopyridine (3,4-DAP)
  • have had a seizure
  • have kidney problems
  • have liver problems
  • are pregnant or plan to become pregnant. It is not known if FIRDAPSE will harm your unborn baby. You and your doctor will decide if you should take FIRDAPSE while you are pregnant.
  • are breastfeeding or plan to breastfeed. It is not known if FIRDAPSE passes into your breast milk. Talk to your doctor about the best way to feed your baby while taking FIRDAPSE.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take FIRDAPSE?

  • Take FIRDAPSE exactly as your doctor tells you to take it. Do not change your dose of FIRDAPSE.
  • Do not take more than 2 tablets of FIRDAPSE at one time or more than 8 tablets of FIRDAPSE in a 24-hour period.
  • FIRDAPSE can be taken with or without food.
  • If you miss a dose of FIRDAPSE, skip that dose and take your next dose at your next scheduled dose time. Do not double your dose to make up the missed dose.
  • Do not take FIRDAPSE together with other medicines known to increase the risk of seizures.
  • If you take too much FIRDAPSE, call your doctor or go to the nearest hospital emergency room right away.

What are the possible side effects of FIRDAPSE?

FIRDAPSE may cause serious side effects, including:

  • Seizures. See "What is the most important information I should know about FIRDAPSE?"
  • Serious allergic reactions, such as anaphylaxis. FIRDAPSE can cause serious allergic reactions. Stop taking FIRDAPSE and call your doctor right away or get emergency medical help if you have:
    • shortness of breath or trouble breathing
    • swelling of your throat or tongue
    • ­hives
  • The most common side effects of FIRDAPSE include:
    • tingling around the mouth, tongue, face, fingers, toes, and other body parts
    • upper respiratory infection
    • stomach pain
    • nausea
    • diarrhea
    • headache
    • increased liver enzymes
    • back pain
    • high blood pressure
    • muscle spasms

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of FIRDAPSE.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store FIRDAPSE?

  • Store FIRDAPSE at 68ºF to 77ºF (20ºC to 25ºC).
  • Safely throw away FIRDAPSE that is out of date or no longer needed.

Keep FIRDAPSE and all medicines out of the reach of children.

If you would like more information, ask your doctor or pharmacist for additional information about FIRDAPSE.

The active ingredient in FIRDAPSE is amifampridine phosphate. Inactive ingredients are calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.

Please see full Prescribing Information for additional Important Safety Information.

What is FIRDAPSE®?

FIRDAPSE is a prescription medicine used to treat adults 17 years of age or older with Lambert-Eaton myasthenic syndrome (LEMS). The safety and efficacy of FIRDAPSE in patients under the age of 17 has not been established.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about FIRDAPSE?

  • FIRDAPSE can cause seizures.
    • You could have a seizure even if you never had a seizure before.
    • Do not take FIRDAPSE if you have ever had a seizure.

Stop taking FIRDAPSE and call your doctor right away if you have a seizure while taking FIRDAPSE.

Do not take FIRDAPSE if you:

  • have ever had a seizure.
  • are allergic to amifampridine phosphate, or another aminopyridine.

Before you take FIRDAPSE, tell your doctor about all of your medical conditions, including if you:

  • are taking another aminopyridine, such as compounded 3,4-diaminopyridine (3,4-DAP)
  • have had a seizure
  • have kidney problems
  • have liver problems
  • are pregnant or plan to become pregnant. It is not known if FIRDAPSE will harm your unborn baby. You and your doctor will decide if you should take FIRDAPSE while you are pregnant.
  • are breastfeeding or plan to breastfeed. It is not known if FIRDAPSE passes into your breast milk. Talk to your doctor about the best way to feed your baby while taking FIRDAPSE.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take FIRDAPSE?

  • Take FIRDAPSE exactly as your doctor tells you to take it. Do not change your dose of FIRDAPSE.
  • Do not take more than 2 tablets of FIRDAPSE at one time or more than 8 tablets of FIRDAPSE in a 24-hour period.
  • FIRDAPSE can be taken with or without food.
  • If you miss a dose of FIRDAPSE, skip that dose and take your next dose at your next scheduled dose time. Do not double your dose to make up the missed dose.
  • Do not take FIRDAPSE together with other medicines known to increase the risk of seizures.
  • If you take too much FIRDAPSE, call your doctor or go to the nearest hospital emergency room right away.

What are the possible side effects of FIRDAPSE?

FIRDAPSE may cause serious side effects, including:

  • Seizures. See "What is the most important information I should know about FIRDAPSE?"
  • Serious allergic reactions, such as anaphylaxis. FIRDAPSE can cause serious allergic reactions. Stop taking FIRDAPSE and call your doctor right away or get emergency medical help if you have:
    • shortness of breath or trouble breathing
    • swelling of your throat or tongue
    • ­hives
  • The most common side effects of FIRDAPSE include:
    • tingling around the mouth, tongue, face, fingers, toes, and other body parts
    • upper respiratory infection
    • stomach pain
    • nausea
    • diarrhea
    • headache
    • increased liver enzymes
    • back pain
    • high blood pressure
    • muscle spasms

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of FIRDAPSE.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store FIRDAPSE?

  • Store FIRDAPSE at 68ºF to 77ºF (20ºC to 25ºC).
  • Safely throw away FIRDAPSE that is out of date or no longer needed.

Keep FIRDAPSE and all medicines out of the reach of children.

If you would like more information, ask your doctor or pharmacist for additional information about FIRDAPSE.

The active ingredient in FIRDAPSE is amifampridine phosphate. Inactive ingredients are calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.

Please see full Prescribing Information for additional Important Safety Information.